FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

BMS Launches Orencia Autoinjector Product

July 29, 2016

Bristol-Myers Squibb launched its combination Orencia ClickJect for adults with moderate to severe rheumatoid arthritis.

The Orencia auto injector delivers 125 mg subcutaneously via push button operation and injection confirmation, which may reduce user errors.

Orencia is the only RA biologic that offers three administration options: IV infusion, prefilled syringe and Autoinjector. — Tamra Sami

View today's stories